Psilocybin Therapy for Depression in Parkinson's Disease
Psilocybin Therapy for Depression in Parkinson's Disease
- Age
- 40 – 80
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Joshua Woolley, MD, PhD · Other
This trial is looking for people with Parkinson's Disease and depression. Participants will receive psilocybin therapy to see if it helps improve their symptoms.
You may be able to join if
- I am between 40 and 80 years old.
- I can speak and write in English.
- I have been diagnosed with Parkinson's disease.
- I currently have depressive symptoms.
- I can attend all in-person visits at UCSF and some virtual visits.
- I have a primary care provider or mental health professional managing my care.
You may not be able to join if
- I experience psychotic symptoms that affect my insight.
- I have significant cognitive impairment.
- I regularly take medications that may interact with psilocybin.
- I have a health condition that makes this study unsafe or unfeasible.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
Loading trial locations…